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ABSTRACT 
Insight of evidence that some complications of diabetes mellitus due to hyperglycemia, we 
investigated the effect of T.arjuna bark extract on serum, liver and kidney marker enzymes in 
alloxan - induced diabetic rats. T. arjuna was administered orally at a doses of 250 and 500 
mg/kg body weight for      30 days, after which serum liver and kidney tissues were assayed 
for the degree of pathological changes by means of markers such as alkaline phosphatase 
(ALP), acid phosphatase (ACP), alanine amino transferase (ALT), aspartate amino 
transferase (AST) and lactate dehydrogenase (LDH) resulted in a significant reduction in 
serum and tissue of liver and kidney marker enzymes when compared with control rats T. 
arjuna at a dose of 500 mg/kg body weight exhibited higher efficacy. 
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INTRODUCTION 
 
Diabetes mellitus is a major disease 
affecting nearly 10% of the population.  In 
spite of the introduction of hypoglycemic 
agents, diabetes and related complications 
continue to be a major medical problem.  
Furthermore, insulin resistance or 
decreased level of insulin is a 
characteristic feature of cirrhosis
1. The 
acute hyperglycemic causes life 
threatening ketoacidosis and also chronic 
hyperglycemia leads to conditions like 
retinopathy, nephropathy and peripheral 
insufficiencies.  Liver disease is one of the 
leading causes of death in persons with 
diabetes
2. 
 
Alloxan produces oxygen radicals in the 
body, which cause pancreatic injury and 
could be responsible for increased blood 
sugar seen in the animals
3.  However, it is 
found that action is not specific to 
pancrease as other organs such as liver, 
kidney and haemopoietic system also 
affected by alloxan, administration as seen 
from the elevation of marker enzymes
4. 
 
Many indigenous Indian medicinal plants 
have been found to be successfully used to 
manage diabetes.  The incidence of which 
is very high all over the world especially 
in India.  The reason is that plant drugs 
could be effective and at the same time 
have less or no side effects. The medicinal 
plant  T.arjuna  is widely used in the 
indigenous system of medicine practiced 
in India for several ailments
5, 6. Thus there 
is no reports on the ability of T.arjuna bark 
extract in serum liver and kidney marker 
enzymes in diabetes. Hence, the present 
study has been under taken to evaluate the 
protective role of ethanolic extract of 
T.arjuna  on serum, liver and kidney 
marker enzymes such as ALP, ACP, ALT, 
AST and LDH in alloxan-induced diabetic 
rats.  
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METHODS 
Plant material and preparation of 50% 
ethanolic extract 
 
The wet Terminalia arjuna bark were 
collected from Siruvani coastal of Agali in 
Kerala. The specimen was identified and 
certified by Botanical Survey of India 
(BSI) Coimbatore.  
 
Terminalia arjuna was used in the form of 
crude 50% ethanol extract and this extract 
was prepared according to the traditional 
system of medicine. The shade dried and 
coarsely powdered stem bark (1kg) was 
extracted with 50% alcohol in the cold for 
72 hours.  The extract was filtered and 
distilled on water bath, a reddish brown 
syrupy mass was obtained and it was 
finally dried at low temperature under 
reduced pressure in a rotary evaporator. A 
crude residue (75g) was obtained giving a 
yield of 7.5%.  The serum and tissue 
marker enzymes were evaluated by oral 
administration of the extract on  alloxan 
induced diabetic rats. 
 
Animals 
 
Male albino rats of Wistar strain weighing 
about 150 – 200 g, obtained from the 
Medical College of Trichur (Kerala) were 
used for the study. They were fed a 
standard rat pellet diet  (Sai Durga feeds, 
Bangalore) and water was provided 
adlibitum  and maintained under standard 
laboratory conditions. (Temperature 24-
28° C, relative humidity 60 - 70%).   
Animals described as fasted were deprived 
of food for 16 h but had free access to 
water.  Clearance for the handling of 
experimental animals was obtained from 
the Ethical committee constituted for the 
purpose (CPCSEANO: 659/02/a). 
 
Alloxan - induced diabetes 
 
Diabetes was induced by a single ip 
injection of 120 mg/kg of alloxan 
monohydrate (S.D Fine – Chem. Ltd., 
Mumbai, India), in sterile saline
7.  After 72 
hours of alloxan injection, the diabetic rats 
(glucose level > 250 mg/dl) were separated 
and used for the study 
8. 
 
Experimental procedure   
 
The animals were divided in to 6 groups of 
6 each.  Group I served as normal healthy 
control. Group II (untreated diabetic 
control). Group III diabetic rats given 
T.arjuna  bark extract (250 mg/kg body 
weight).  Group IV diabetic rats given 
T.arjuna  bark extract (500 mg/kg body 
weight). Group V control rats given 
T.arjuna  bark extract (250 mg/kg body 
weight) Group VI control rats given 
T.arjuna  bark extract (500 mg/kg body 
weight). The drug was administered for the 
period of 30 days. 
 
After the experimental regimen, the 
animals were sacrificed by    cervical 
dislocation under mild chloroform 
anesthesia.  Blood was collected on 
decapitation and serum was separated by 
centrifugation (for 20 min at 2000 rpm). 
The liver and kidney were excised 
immediately and thoroughly washed in ice 
- cold saline. The serum and tissues were 
collected and used for biochemical 
experiments. 
 
Biochemical estimations 
 
Serum glucose was estimated by GOD / 
POD method 
9.  Activities of ALP
10 
(alkaline phosphatase), ACP
10 (acid 
phosphatase) ALT
11 (alanine amino 
transaminase, AST (aspartate amino 
transaminase and LDH
12 (lactate 
dehydrogenase) were assayed in serum, 
liver and kidney of experimental animals.   
 
 
RESULT 
 
As shown in Table 1, the levels of glucose 
in serum of alloxan induced diabetes rats 
were found to be significantly elevated as 
compared with    control rats. Oral 
administration of T.arjuna (250 and 500 
mg/kg body weight)  restored the glucose 
level to the near normal in diabetic rats. 
 
Table 2 depicts the activities of serum 
marker enzymes in diabetes when 
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compared to control rats. The increased 
activity of ALP, ACP, ALT, AST and 
LDH after T. arjuna treatment at a dose of 
250 and 500 mg/kg body weight become 
increased to near normal.  There was no 
significant change in   T. arjuna (250 and 
500 mg/kg body weight) treated control 
rats in the above mentioned parameters. 
 
Table 3 shows the activities of ALP, ACP, 
ALT, AST and LDH in liver and kidney 
tissues of different groups of experimental 
animals.  The activities were increased 
significantly in diabetic animals when 
compared with control rats. Oral 
administration of T.arjuna bark extract at a 
dose of 250 and   500 mg/kg body weight 
were lowered the activities.  There was no 
significant change in the activities of these 
enzymes in T.arjuna treated control rats. 
 
DISCUSSION 
 
From the observations made in Table 1 it 
is clear that the administration of T.arjuna 
brings down the serum glucose levels 
considerably in alloxan induced diabetic 
animal.  The glucose lowering activity 
observed in the diabetic animals may be 
due to the stimulation of β - cells of 
pancreatic islets
13   
 
Estimating the activities of serum and 
tissue marker enzymes like ALP, ACP, 
AST, ALT and LDH can make assessment 
of liver function, when liver and kidney 
cell plasma membrane is damaged, a 
variety of enzymes normally located in the 
cytosol are released in to the blood stream.  
Their estimation in the serum is a useful 
quantitative marker of the extent and type 
of hepatocellular damage
14 
 
In the present study we have observed an 
increased in the level of serum liver and 
kidney marker enzymes in alloxan induced 
diabetes indicating that alloxan 
administration produced hepatic damage 
and an increase in membrane transport is 
evidenced by enhanced activities of 
membrane bound enzymes, ALP and ACP 
in the kidney
15. ALP and ACP are 
ubiquitous in nature, their primary role of 
extra cellular phosphatases is to provide 
inorganic phosphate for cell growth by 
hydrolysis of external phosphate esters 
which do not penetrate the cytoplasmic 
membrane
16 and also ALP is the prototype 
of these enzymes that reflect the 
pathological alteration in biliary flow
17. 
Oral administration of T.arjuna bark 
extract to lower the elevated serum 
enzyme level.  
 
The serum, liver and kidney levels of AST 
and ALT have also found    to become 
elevated in diabetic induced animals, 
whenever disease process affects liver cell 
integrity
18. Transaminases (AST &ALT) 
which are active in absence of insulin 
because of availability of amino acids in to 
blood of diabetes are responsible for the 
increased gluconeogenesis and ketogenesis 
observed in diabetics
19. Oral 
administration of T.arjuna bark extract 
(250 & 500 mg/kg body weight) to lower 
the elevated serum enzyme levels.  In view 
of this the extract mediated reduction in 
the levels of ALT and AST towards the 
respective normal values is an indication 
of stabilization of plasma membrane as 
well as repair of hepatic, tissue damage 
caused by alloxan. This effect is in 
agreement with the commonly possesses 
isoenzymes recognized as markers for 
liver and muscle legions accepted view 
that serum level of transaminases return to 
normal with restore the normal function of 
liver and kidney
20. 
 
LDH is a cytosolic enzyme is involved in 
biochemical regulation (i.e. 
interconversion of lactate to pyruvate) 
reactions of the body tissues and fluids, 
LDH products the cofactor (NAD
+ / 
NADH) for glycolytic enzymes
21. Serum, 
liver & kidney LDH is almost doubled in 
alloxan induced diabetic animals. This is 
line with finding of others
22. 
Administration of T.arjuna  bark extract 
the LDH level was found to decreased and 
this was similar to that of normal rats. The 
decreases of LDH activity in serum, liver 
and kidney there by decreasing the 
endogenous glucose production. 
 
Pages 8 - 15  4
In conclusion it can be suggested that the 
oral administration of T.arjuna bark 
extract can revert the increased activity of 
marker enzymes it is found in diabetic rats 
which clearly indicates the protective role 
of  T.arjuna  bark extract in diabetes 
mellitus.  More over the dose at 500 mg/kg 
body weight have more efficacy. However 
T.arjuna  does not alter the assayed 
parameter in control rats, there by 
indicating its non-toxic nature in the 
applied dosage.  
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Table 1. Effect of Terminalia arjuna stem bark on serum glucose, levels in alloxan induced diabetic rats 
   Parameters   Group 1 
Control 
Group II 
Diabetic 
Group III 
Diabetic +TA 
250mg/kg 
Group IV 
Diabetic +TA 
500mg/kg 
Group V 
Control +TA 
250mg/kg 
Group VI 
Control +TA 
500mg/kg 
Serum 
Glucose (mg/dl) 
 
98.33  ±  02.66
b 
 
302.67 ±  22.35
f 
 
125.60 ±  24.73
e 
 
82.50 ±  04.72
a 
 
106.67 ±  0.625
b 
 
113.17 ± 14.25
b 
 
 
Table  2. Effect of Terminalia arjuna stem bark on serum marker enzymes in alloxan – induced diabetic rats. 
             
Parameters  
Group 1 
Control 
Group II 
Diabetic 
Group III 
Diabetic +TA 
250mg/kg 
Group IV 
Diabetic +TA 
500mg/kg 
Group V 
Control +TA 
250mg/kg 
Group VI 
Control +TA 
500mg/kg 
Serum 
ALP
1 
ACP
2 
AST
3 
ALT
4 
LDH
5 
 
406 ± 1.63
d 
125.24 ±  2.31
e 
54.82 ± 1.88
c 
69.38 ± 4.02
c 
357.28 ±  23.74
d 
 
546.33 ± 8.00
f 
225.25 ±  2.83
f 
183.63 ±  7.93
f 
212.17 ± 3.39
f 
705.38 ±  58.26
f 
 
374.38 ± 3.88
a 
113.69 ±  2.40
a 
49.31 ± 5.12
a 
76.28 ± 2.81
d 
237.29 ± 41.68
e 
 
426.38 ± 8.41
e 
124.24 ± 4.48
c 
57.64 ± 4.27
e 
111.85 ± 8.66
e 
340.69 ± 25.98
a 
 
402 ± 2.56
d 
123.20 ± 2.74
e 
53.93 ± 3.13
c 
65.34 ± 2.97
c 
335.89 ± 11.69
d 
 
401.12 ± 2.52
d 
124.24 ± 5.55
e 
56.37 ± 2.88
c 
67.51 ± 2.81
c 
335.33 ± 4.74
d 
 
Units: 
1. µ moles of phenol liberated / L 
2. µ moles of pyruvate liberated / L 
3. µ moles of phosphorous liberated / L 
4. µ moles of pyruvate liberated / L 
5. µ moles of pyruvate liberated / L 
Values are expressed as Mean ± SD (n=6) Means  followed  by a common letter are not significantly differ at p<0.05 (DMRT).
Values are expressed as Mean ± SD (n=6) Means followed by a common letter are not significantly differ at p<0.05 (DMRT).
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Table  3. Effect of Terminalia arjuna stem bark on liver and kidney marker enzymes in alloxan – induced diabetic rats 
Parameters  Group 1 
Control 
Group II 
Diabetic 
Group III 
Diabetic +TA 
250mg/kg 
Group IV 
Diabetic +TA 
500mg/kg 
Group V 
Control +TA 
250mg/kg 
Group VI 
Control +TA 
500mg/kg 
Liver 
ALP
1 
ACP
2 
AST
3 
ALT
4 
LDH
5 
Kidney  
ALP
1 
ACP
2 
AST
3 
ALT
4 
LDH
5 
 
11.88 ±  0.57
d 
13.09 ±  0.38
c 
15.23 ±  1.33
b 
12.43 ± 0.26
c 
84.20 ±  2.83
e 
 
18.88 ± 0.90
b 
20.78 ± 0.13
d 
20.85 ±  1.20
c 
7.45 ±  0.71
d 
111.13 ±  10.91
d 
 
48.57 ±  6.14
f 
31.11 ± 3.24
f 
44.54 ±  1.52
f 
24.06 ±  0.50
f 
179.08 ± 4.62
f 
 
54.11 ±  0.79
f 
42.56 ±  0.79
f 
32.61 ±  3.06
f 
17.35 ± 2.47
f 
203.44 ± 34.78
f 
 
5.38 ±  0.89
a 
13.74 ±  0.48
d 
23.52 ±  2.54
e 
11.05 ±  1.34
a 
69.75 ±  3.90
a 
 
20.84 ±  1.38
d 
17.25 ± 1.71
a 
22.64 ±  0.27
e 
5.20 ±  0.50
a 
94.51 ± 5.01
a 
 
10.05 ± 0.84
b 
16.41 ±  0.47
e 
16.08 ±  1.21
d 
12.65 ±  0.31
e 
78.75 ±  11.95
b 
 
32.78 ±  2.05
e 
23.35 ±  1.12
e 
18.87 ±  1.55
a 
7.05 ±  0.67
c 
112.60 ±  6.90
e 
 
12.21 ±  0.41
d 
12.97 ±  0.80
c 
14.82 ±  0.72
b 
12.16 ±  0.40
c 
80.62 ±  4.48
e 
 
18.38 ±  1.02
b 
19.64 ±  1.24
d 
22.42 ± 1.14
c 
6.59 ±  0.19
d 
107.13 ± 14.62
d 
 
10.36 ± 0.57
d 
13.04 ±  1.68
 c 
15.73 ±  0.95
b 
12.59 ±  0.41
c 
80.66 ±  0.55
e 
 
19.02 ±  0.59
b 
20.68 ±  0.60
d 
19.81 ±  1.66
c 
7.94 ±  0.37
d 
103.62 ±  3.24
d 
 
 
 
Units: 
1. n moles of phenol liberated / min / mg protein 
2. n moles of phenol liberated / min / mg protein 
3. µ moles of pyruvate liberated / min / mg protein 
4. µ moles of pyruvate liberated / min / mg protein 
5. µ moles of pyruvate liberated / min / mg protein 
Values are expressed as Mean ± SD (n=6)  
 
Means followed by a common letter are not significantly differ at p<0.05 (DMRT).
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